View Document Preview and Link Document Date: 2008-10-07 11:26:32 Open Document File Size: 522,38 KB Share Result on Facebook
Company Bayer / Aventis / The Working Group / Coleman / Bristol-Myers Squibb / / Country South Africa / Peru / Kenya / United States / Brazil / China / Morocco / India / / Currency USD / / Event Product Issues / / Facility Institute of Medicine / / IndustryTerm community-based insurance / basic health services / retail price / pharmaceutical industry / manufacturing costs / retail / health services / basic infrastructure / community insurance / larger healthcare system / manufacturing facilities / rst nonprofit pharmaceutical / pharmaceutical / healthcare / medicine supply systems / food / quality assurance systems / orginator products / technology needs / high manufacturing cost / chemical entities / needed health services / retail prices / malaria treatment / social health insurance / generic products / technology transfer / / MedicalCondition Innovation Treating priority diseases / rheumatism / TB / leishmaniasis / priority diseases / Chagas disease / illness / cardiovascular diseases / parasitic diseases / African trypanosomiasis / multidrug-resistant malaria / specific diseases / lack of coordination / basic and chronic absolute lack / hypertension / cancer / disease / malaria / neglected diseases / diabetes / diseases / AIDS / infectious diseases / chronic diseases / prevalent diseases / Tropical Diseases / only significant tropical disease / / MedicalTreatment antibiotics / / Organization World Health Organization / Institute of Medicine / United Nations International Children's Emergency Fund / Melinda Gates Foundation / World Bank / United Nations / HAI / Commission on Macroeconomics and Health / Brazilian government / WHO Commission on Intellectual Property Rights / Innovation / and Public Health / / Product didanosine / medicines / / SocialTag 
TF5-medicines[removed]indd